First Time Loading...

Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 107.53 USD 0.63% Market Closed
Updated: Apr 27, 2024

Abbott Laboratories
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abbott Laboratories
Long-Term Debt Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Long-Term Debt
$13.6B
CAGR 3-Years
-8%
CAGR 5-Years
-6%
CAGR 10-Years
15%
Becton Dickinson and Co
NYSE:BDX
Long-Term Debt
$14.1B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
14%
Boston Scientific Corp
NYSE:BSX
Long-Term Debt
$8.6B
CAGR 3-Years
-2%
CAGR 5-Years
12%
CAGR 10-Years
7%
Edwards Lifesciences Corp
NYSE:EW
Long-Term Debt
$597m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Stryker Corp
NYSE:SYK
Long-Term Debt
$10.9B
CAGR 3-Years
-6%
CAGR 5-Years
5%
CAGR 10-Years
15%
Intuitive Surgical Inc
NASDAQ:ISRG
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Abbott Laboratories's Long-Term Debt?
Long-Term Debt
13.6B USD

Based on the financial report for Mar 31, 2024, Abbott Laboratories's Long-Term Debt amounts to 13.6B USD.

What is Abbott Laboratories's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
15%

Over the last year, the Long-Term Debt growth was -7%. The average annual Long-Term Debt growth rates for Abbott Laboratories have been -8% over the past three years , -6% over the past five years , and 15% over the past ten years .